1. Home
  2. HSDT vs TGL Comparison

HSDT vs TGL Comparison

Compare HSDT & TGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • TGL
  • Stock Information
  • Founded
  • HSDT 2014
  • TGL 2020
  • Country
  • HSDT United States
  • TGL United States
  • Employees
  • HSDT N/A
  • TGL N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TGL Retail: Computer Software & Peripheral Equipment
  • Sector
  • HSDT Health Care
  • TGL Technology
  • Exchange
  • HSDT Nasdaq
  • TGL Nasdaq
  • Market Cap
  • HSDT 2.5M
  • TGL 2.4M
  • IPO Year
  • HSDT N/A
  • TGL 2022
  • Fundamental
  • Price
  • HSDT $0.49
  • TGL $0.19
  • Analyst Decision
  • HSDT Buy
  • TGL
  • Analyst Count
  • HSDT 2
  • TGL 0
  • Target Price
  • HSDT $24.00
  • TGL N/A
  • AVG Volume (30 Days)
  • HSDT 236.6K
  • TGL 1.6M
  • Earning Date
  • HSDT 11-12-2024
  • TGL 02-12-2025
  • Dividend Yield
  • HSDT N/A
  • TGL N/A
  • EPS Growth
  • HSDT N/A
  • TGL N/A
  • EPS
  • HSDT N/A
  • TGL N/A
  • Revenue
  • HSDT $502,000.00
  • TGL $8,810,305.00
  • Revenue This Year
  • HSDT N/A
  • TGL N/A
  • Revenue Next Year
  • HSDT $8.97
  • TGL N/A
  • P/E Ratio
  • HSDT N/A
  • TGL N/A
  • Revenue Growth
  • HSDT N/A
  • TGL N/A
  • 52 Week Low
  • HSDT $0.37
  • TGL $0.15
  • 52 Week High
  • HSDT $9.50
  • TGL $12.60
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 44.03
  • TGL 29.19
  • Support Level
  • HSDT $0.43
  • TGL $0.15
  • Resistance Level
  • HSDT $0.76
  • TGL $0.27
  • Average True Range (ATR)
  • HSDT 0.08
  • TGL 0.04
  • MACD
  • HSDT -0.01
  • TGL 0.01
  • Stochastic Oscillator
  • HSDT 17.91
  • TGL 11.33

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.

Share on Social Networks: